Cargando…

Retraction Note: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer

Detalles Bibliográficos
Autores principales:	Zhang, Haiyong, Wu, Jing, Yuan, Jinqiu, Li, Huafu, Zhang, Yawei, Wu, Wang, Chen, Wei, Wang, Chunming, Meng, Sijun, Chen, Songyao, Huo, Mingyu, He, Yulong, Zhang, Changhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Retraction Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845271/ https://www.ncbi.nlm.nih.gov/pubmed/35168643 http://dx.doi.org/10.1186/s13046-022-02268-7

Ejemplares similares

Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer
por: Zhang, Haiyong, et al.
Publicado: (2021)

A thioredoxin reductase inhibitor ethaselen induces growth inhibition and apoptosis in gastric cancer
por: Wu, Wang, et al.
Publicado: (2020)

To inhibit TrxR1 is to inactivate STAT3–Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors
por: Busker, Sander, et al.
Publicado: (2020)

Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells
por: He, Wei, et al.
Publicado: (2019)

TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport
por: Zhang, Yushuo, et al.
Publicado: (2017)

Inhibiting TrxR suppresses liver cancer by inducing apoptosis and eliciting potent antitumor immunity
por: Lei, Hong, et al.
Publicado: (2018)

Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk
por: Fan, Cun-dong, et al.
Publicado: (2017)

Licochalcone a Induces ROS-Mediated Apoptosis through TrxR1 Inactivation in Colorectal Cancer Cells
por: Wu, Peng, et al.
Publicado: (2020)

Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors
por: Xia, Yiqun, et al.
Publicado: (2021)

Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma
por: Wang, Sicong, et al.
Publicado: (2023)

Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells
por: Chen, Xi, et al.
Publicado: (2018)

Activation of TAp73 and inhibition of TrxR by Verteporfin for improved cancer therapy in TP53 mutant pancreatic tumors
por: Acedo, Pilar, et al.
Publicado: (2019)

Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
por: Zhang, Qianqian, et al.
Publicado: (2019)

Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells
por: Galassi, Rossana, et al.
Publicado: (2021)

Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
por: Zhang, Qianqian, et al.
Publicado: (2022)

Changes of 8-OHdG and TrxR in the Residents Who Bathe in Radon Hot Springs
por: Yanxiao, Gao, et al.
Publicado: (2019)

Alantolactone promotes ER stress‐mediated apoptosis by inhibition of TrxR1 in triple‐negative breast cancer cell lines and in a mouse model
por: Yin, Changtian, et al.
Publicado: (2019)

Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a
por: Rajamanickam, Vinothkumar, et al.
Publicado: (2020)

Plasma and Synovial Fluid TrxR Levels are Correlated With Disease Risk and Severity in Patients With Rheumatoid Arthritis
por: Xie, Zhijun, et al.
Publicado: (2016)

MiR-23-TrxR1 as a novel molecular axis in skeletal muscle differentiation
por: Mercatelli, Neri, et al.
Publicado: (2017)

Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death
por: Busker, S., et al.
Publicado: (2020)

PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation
por: Yin, Zhi-Xian, et al.
Publicado: (2017)

Design, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxR
por: Hu, Jinhui, et al.
Publicado: (2023)

DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1‐mediated antioxidant effects
por: Rong, Yefei, et al.
Publicado: (2020)

Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation
por: Chen, Weiqian, et al.
Publicado: (2016)

A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells
por: Cheng, Xinlai, et al.
Publicado: (2014)

Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
por: Xu, Lianrong, et al.
Publicado: (2019)

Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy
por: Jovanović, Mirna, et al.
Publicado: (2020)

Mitochondrial TrxR2 regulates metabolism and protects from metabolic disease through enhanced TCA and ETC function
por: Chocron, E. Sandra, et al.
Publicado: (2022)

Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo
por: Fan, C, et al.
Publicado: (2014)

Sec-containing TrxR1 is essential for self-sufficiency of cells by control of glucose-derived H(2)O(2)
por: Peng, X, et al.
Publicado: (2014)

miR-125a Suppresses TrxR1 Expression and Is Involved in H(2)O(2)-Induced Oxidative Stress in Endothelial Cells
por: Chen, Fangjie, et al.
Publicado: (2018)

Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox Homeostasis
por: De Franco, Michele, et al.
Publicado: (2022)

PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway
por: Li, Huafu, et al.
Publicado: (2021)

Self-Assembled Polymeric Micellar Nanoparticles as Nanocarriers for Poorly Soluble Anticancer Drug Ethaselen
por: Li, Xinru, et al.
Publicado: (2009)

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer
por: Chen, Gong, et al.
Publicado: (2017)

A possible role for selenoprotein glutathione peroxidase (GPx1) and thioredoxin reductases (TrxR1) in thyroid cancer: our experience in thyroid surgery
por: Metere, Alessio, et al.
Publicado: (2018)

Selenium-ruthenium complex blocks H1N1 influenza virus-induced cell damage by activating GPx1/TrxR1
por: Li, Yinghua, et al.
Publicado: (2023)

Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy
por: Miao, Xiaofei, et al.
Publicado: (2021)

BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC
por: Wang, Huijin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s1ch7m0nvkqvt2aqqrqd2a085e